Health care and pharmaceutical companies hide behind the veil of helping others, but their behavior in the U.S. is nothing short of criminal.

Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.
The market is whipping around like crazy this morning. I’m not sure why, but it matters to me less and less, because I’ve been deliberately reshaping my options portfolio to have increasingly distant expirations. I’ve got a mere 2 January expirations now, and my average DTE across 27 positions is 136 days (nearly 5 months), so I’m not letting the minute by minute oddities bug me.
In the meanwhile, I’d like to suggest that semiconductors are at a possible reversal point (this is SMH):

Just like 3-D printing was little more than a financial product for the investment banks to trot out, only to have it crash and burn, so, too, has all the gene editing companies that were supposed to be such a big deal. The sector’s a wreck, and here are the two market leaders to illustrate that point.

The process began with the leveling off of inflation’s momentum and continued as the global economy began to show signs of weakness (e.g. US manufacturing deceleration and developing supply chain slack among several other problem areas as exposed during the current earnings season).
While the nominal sector (HUI or the ETFs, GDX and GDXJ) has been bouncing within its intact downtrend it would be best to track other macro considerations along with the chart TA, which could signal a new bull phase by either completing a daily chart bottom/base (which nearly happened on Wednesday, but at least temporarily failed as the index and ETFs did not take out the October 4th highs) or completing a final decline, preferably amid much fear and angst among whatever inflation bugs may still be infesting the sector.
(more…)